Taho Pharmaceuticals Ltd. (TPEX:6467)
Taiwan · Delayed Price · Currency is TWD 127.00
+4.50 (3.67%)
At close: May 29, 2026
Taho Pharmaceuticals Market Cap
Taho Pharmaceuticals has a market cap or net worth of 6.53 billion as of May 29, 2026. Its market cap has increased by 117.47% in one year.
Market Cap
6.53B
Enterprise Value
6.19B
Revenue
7.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
127.00
Market Cap Chart
Since August 14, 2014, Taho Pharmaceuticals's market cap has increased from 2.09B to 6.53B, an increase of 212.28%. That is a compound annual growth rate of 10.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 6.53B | 13.90% |
| Dec 31, 2025 | 5.73B | 151.98% |
| Dec 31, 2024 | 2.27B | 1,107.48% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharmasaga | 15.23B |
| TCM Biotech International | 9.00B |
| Libo Pharma | 3.24B |
| Anbogen Therapeutics | 1.86B |
| TEH SENG Pharmaceutical Mfg. | 1.79B |
| Protect Animal Health | 1.76B |
| TSA International | 1.74B |
| Timing Pharmaceutial | 1.73B |